Rheumatology International

Papers
(The TQCC of Rheumatology International is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study108
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review78
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt72
Cardiac involvement in primary Sjӧgren’s syndrome65
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review55
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis52
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed52
Epidemiology and genetics of granulomatosis with polyangiitis50
Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study49
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR43
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study39
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study36
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases36
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly33
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study32
Assessment of sarcopenia in patients with fibromyalgia27
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic26
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound24
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201724
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis23
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review23
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey22
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes21
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination21
Resilience in women with primary Sjögren’s syndrome21
Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study20
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development20
Evaluation of Big Five personality factors in women with fibromyalgia: a cross-sectional study19
Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient19
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients19
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown18
The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis17
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey17
COVID-19 in patients with gout on colchicine17
0.1724009513855